Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study

Autor: Mark T. Corkum, Mark K. Buyyounouski, Albert J. Chang, Hans T. Chung, Peter Chung, Brett W. Cox, Juanita M. Crook, Brian J. Davis, Steven J. Frank, Ivan Henriquez, Eric M. Horwitz, Peter Hoskin, I-Chow Hsu, Mira Keyes, Martin T. King, Marisa A. Kollmeier, Daniel J. Krauss, Andrzej M. Kukielka, Gerard Morton, Peter F. Orio, Bradley R. Pieters, Louis Potters, Peter J. Rossi, Timothy N. Showalter, Abhishek A. Solanki, Daniel Song, Ben Vanneste, Eric Vigneault, Piotr A. Wojcieszek, Michael J. Zelefsky, Mitchell Kamrava

Publikováno v: Radiotherapy and oncology, 184:109672. Elsevier Ireland Ltd
Radiotherapy and Oncology, 184:109672. Elsevier Ireland Ltd

Background and Purpose: Local recurrences after previous radiotherapy (RT) are increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate brachytherapy (BT) is an effective and well tolerated treatment option. We sough

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae21e4a6756492ceff8636cf551050d8
https://pure.amc.nl/en/publications/salvage-prostate-brachytherapy-in-radiorecurrent-prostate-cancer(10a618af-3823-438d-acb1-38b682c83559).html

Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer

Autor: Laura Happersett, Michael J. Zelefsky, Marisa A. Kollmeier, Borys Mychalczak, Brett W. Cox, Sean McBride, Isaac X Pei, Madhur Garg, Zhigang Zhang, Mary Lin, R.M. Gewanter, Melissa Varghese, Debra A. Goldman

Publikováno v: Int J Radiat Oncol Biol Phys

PURPOSE: To report toxicity outcomes, prostate-specific antigen (PSA) relapse, and cumulative incidence posttreatment biopsy results among patients treated on a prospective dose escalation study using ultra-hypofractionated stereotactic body radiatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0bfdb03adb69ba8169746c6761772d6
https://doi.org/10.1016/j.ijrobp.2018.12.045

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

Autor: Chang AJ; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., McBride S; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Keyes M; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Chung HT; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Davis BJ; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Cox BW; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Crook J; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Demanes DJ; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Hsu IC; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Kamrava M; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Krauss DJ; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Morton G; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Orio Iii PF; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Roach Iii M; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Venkat PS; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Vigneault E; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY., Zelefsky MJ; Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Sep 13, pp. JCO1800626. Date of Electronic Publication: 2018 Sep 13.